Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 1/20 | 0.59 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.44 |
| ▸ | C1S | P09871 | 1/20 | 0.44 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | RXRB | P28702 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4360630 | 0.94 | TPMT (0.52) | TPMTHCAR1PRSS1PRSS2C1S | |
| SCHEMBL16077608 | 0.89 | TPMT (0.48) | TPMTHCAR1PRSS1PRSS2C1S | |
| Toluene SCHEMBL29061412 | 0.87 | TPMT (0.52) | TPMTHCAR1RXRARXRBALDH1A1 | |
| SCHEMBL668260 | 0.85 | TPMT (0.44) | TPMTHCAR1HPGDPARP1HCAR2 | |
| SCHEMBL29912669 | 0.85 | TPMT (0.44) | TPMTHCAR1HPGDPARP1HCAR2 | |
| SCHEMBL15935951 | 0.84 | CES2 (0.44) | TPMTHCAR1HPGDPARP1HCAR2 | |
| SCHEMBL13335612 | 0.84 | TPMT (0.43) | TPMTHCAR1PRSS1PRSS2C1S | |
| SCHEMBL15700662 | 0.84 | TPMT (0.43) | TPMTHCAR1HPGDALDH1A1PARP1 | |
| SCHEMBL16034945 | 0.82 | TPMT (0.41) | TPMTHCAR1PRSS1PRSS2C1S | |
| Benzoyl Chloride SCHEMBL28505141 | 0.80 | CES2 (0.50) | TPMTRXRARXRBALDH1A1PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 965 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005364-B | Cement board and production process thereof and application of cement board in disassembly-free template | Tangshan Wanju Building Materials Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-121570997-A | Preparation method of separation membrane, separation membrane and application of separation membrane | 北京碧水源分离膜科技有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-116135900-B | Binder for polyurethane concrete pavement for cold recycling of asphalt mixture reclaimed materials (RAP) | 万华化学（北京）有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-119431424-A | Silicon oxime ester-containing photoinitiator, preparation method and application thereof | 常州强力先端电子材料有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-115895571-B | Polyurethane adhesive for road paving and preparation method thereof | 万华化学集团股份有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-112851547-B | Fluorene oxime ester compound, preparation method thereof and photosensitive resin composition | 常州强力先端电子材料有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-118122025-A | Vitamin D2 production process and equipment | 汇鑫生物科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-118005364-A | Cement board and production process thereof and application of cement board in disassembly-free template | 唐山市万居建材有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117986231-A | Oxime ester photoinitiator, preparation method and application thereof | 常州强力电子新材料股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-116333672-B | UV (ultraviolet) binder suitable for camera module and preparation method thereof | 广东德聚技术股份有限公司 | 2023-11-17 | — | — | CN | claimed |
| EP-1125913-B1 | Preparation of 3,5-bis-(trifluormethyl)-benzoylchlorid and novel benzoylhalides: 3,5-bis-(trihalomethyl)- and 3,5-dimethyl- | BAYER AG (DE) | 2003-04-09 | — | — | EP | claimed |
| US-6420601-B2 | FREE RADICAL CHLORINATION; FLUORINATION WITH HYDROGEN FLUORIDE AND/OR ANTIMONY PENTAFLUORIDE; CONVERTING THE BENZOYL FLUORIDE TO CHLORIDE BY REACTING WITH SILICON TETRACHLORIDE IN LEWIS ACID; CHEMICAL INTERMEDIATES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-07-16 | — | — | US | claimed |
| EP-1125913-A1 | Preparation of 3,5-bis-(trifluormethyl)-benzoylchlorid and novel benzoylhalides: 3,5-bis-(trihalomethyl)- and 3,5-dimethyl- | BAYER AG (DE) | 2001-08-22 | — | — | EP | claimed |
| US-20010014759-A1 | Free radical chlorination; fluorination with hydrogen fluoride and/or antimony pentafluoride; converting the benzoyl fluoride to chloride by reacting with silicon tetrachloride in lewis acid; chemical intermediates | LANXESS DEUTSCHLAND GMBH (DE) | 2001-08-16 | — | — | US | claimed |
| EP-0639559-B1 | Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines | ROHM & HAAS (US) | 1997-10-15 | — | — | EP | claimed |
| EP-0639559-A1 | Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines | ROHM AND HAAS COMPANY (US) | 1995-02-22 | — | — | EP | claimed |
| EP-0266730-B1 | Esters of hexadydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds | MERRELL DOW PHARMA (US) | 1994-08-10 | — | — | EP | claimed |
| WO-1993014055-A1 | PREPARATION OF 2,5-DICHLOROBENZOPHENONES | MAXDEM INCORPORATED (US) | 1993-07-22 | — | — | WO | claimed |
| US-5210313-A | Friedel crafts aryloylation of 1,4-dichlorobenzene and Lewis acids | MAXDEM INCORPORATED (US) | 1993-05-11 | — | — | US | claimed |
| EP-0266730-A1 | Esters of hexadydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds | MERRELL DOW PHARMACEUTICALS INC. (US) | 1988-05-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010014759-A1 | Free radical chlorination; fluorination with hydrogen fluoride and/or antimony pentafluoride; converting the benzoyl fluoride to chloride by reacting with silicon tetrachloride in lewis acid; chemical intermediates | SCLY, SSB, CLIC4 | TPMT 4262/4885HCAR1 2068/4885PRSS1 4831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.